In this study, the PI3K/AKT/GSK-3β/β-catenin signaling pathway was clearly activated in BLM-treated mice, and in TGF-β1-stimulated and DEC1 cDNA-induced cells. The gene discussed is AKT1; the disease is Bloom syndrome.